Davenport & CO LLC Danaher Corp Transaction History

Davenport & CO LLC

$16 Billion
Q2 2024

A detailed history of Davenport & CO LLC transactions in Danaher Corp stock. As of the latest transaction made, Davenport & CO LLC holds 583,204 shares of DHR stock, worth $155 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares

583,204

Previous 585,936 0.47%

Holding current value

$155 Million

Previous $146 Million 0.41%

% of portfolio

0.91%

Previous 0.93%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$235.51 - $267.98 $643,413 - $732,121	-2,732 Reduced 0.47%	583,204 $146 Million
Q1 2024 May 03, 2024	SELL	$224.58 - $256.19 $626,353 - $714,513	-2,789 Reduced 0.47%	585,936 $146 Million
Q4 2023 Jan 23, 2024	BUY	$185.1 - $233.13 $271,541 - $342,001	1,467 Added 0.25%	588,725 $136 Million
Q3 2023 Oct 17, 2023	BUY	$233.08 - $265.59 $14.8 Million - $16.9 Million	63,538 Added 12.13%	587,258 $146 Million
Q2 2023 Jul 20, 2023	SELL	$224.99 - $256.14 $3.3 Million - $3.75 Million	-14,655 Reduced 2.72%	523,720 $126 Million
Q1 2023 Apr 27, 2023	SELL	$239.75 - $277.0 $1.33 Million - $1.54 Million	-5,551 Reduced 1.02%	538,375 $136 Million
Q4 2022 Jan 20, 2023	SELL	$241.42 - $282.29 $820,586 - $959,503	-3,399 Reduced 0.62%	543,926 $0
Q3 2022 Oct 11, 2022	SELL	$247.06 - $1507.4 $2.19 Million - $13.3 Million	-8,851 Reduced 1.59%	547,325 $141 Million
Q2 2022 Jul 18, 2022	SELL	$237.11 - $299.66 $1.59 Million - $2.01 Million	-6,714 Reduced 1.19%	556,176 $141 Million
Q1 2022 May 02, 2022	BUY	$257.27 - $315.76 $336,509 - $413,014	1,308 Added 0.23%	562,890 $165 Million
Q4 2021 Feb 10, 2022	SELL	$292.08 - $329.01 $5.07 Million - $5.72 Million	-17,371 Reduced 3.0%	561,582 $185 Million
Q3 2021 Oct 14, 2021	BUY	$272.21 - $332.43 $7.98 Million - $9.74 Million	29,309 Added 5.33%	578,953 $176 Million
Q2 2021 Jul 28, 2021	SELL	$225.08 - $271.69 $7.02 Million - $8.48 Million	-31,205 Reduced 5.37%	549,644 $148 Million
Q1 2021 Apr 28, 2021	SELL	$212.38 - $245.9 $435,591 - $504,340	-2,051 Reduced 0.35%	580,849 $131 Million
Q4 2020 Jan 13, 2021	SELL	$212.5 - $245.46 $13.9 Million - $16 Million	-65,375 Reduced 10.08%	582,900 $129 Million
Q3 2020 Oct 15, 2020	SELL	$177.16 - $215.33 $628,740 - $764,206	-3,549 Reduced 0.54%	648,275 $140 Million
Q2 2020 Jul 28, 2020	SELL	$128.7 - $176.83 $9.03 Million - $12.4 Million	-70,130 Reduced 9.71%	651,824 $115 Million
Q1 2020 May 05, 2020	SELL	$121.39 - $169.05 $575,024 - $800,789	-4,737 Reduced 0.65%	721,954 $99.9 Million
Q4 2019 Jan 22, 2020	BUY	$133.47 - $153.48 $1.04 Million - $1.19 Million	7,760 Added 1.08%	726,691 $112 Million
Q3 2019 Oct 16, 2019	SELL	$135.4 - $146.47 $1.43 Million - $1.54 Million	-10,545 Reduced 1.45%	718,931 $103 Million
Q2 2019 Jul 10, 2019	SELL	$124.88 - $143.73 $2.94 Million - $3.38 Million	-23,545 Reduced 3.13%	729,476 $104 Million
Q1 2019 Apr 17, 2019	SELL	$97.62 - $132.29 $549,210 - $744,263	-5,626 Reduced 0.74%	753,021 $99.4 Million
Q4 2018 Jan 28, 2019	SELL	$94.85 - $109.54 $2.21 Million - $2.55 Million	-23,321 Reduced 2.98%	758,647 $78.2 Million
Q3 2018 Oct 11, 2018	SELL	$98.13 - $108.9 $91,751 - $101,821	-935 Reduced 0.12%	781,968 $85 Million
Q2 2018 Jul 09, 2018	SELL	$96.1 - $103.24 $1.02 Million - $1.09 Million	-10,587 Reduced 1.33%	782,903 $77.3 Million
Q1 2018 Apr 04, 2018	SELL	$92.16 - $103.8 $604,938 - $681,343	-6,564 Reduced 0.82%	793,490 $77.7 Billion
Q4 2017 Jan 17, 2018	SELL	$85.26 - $94.62 $876,302 - $972,504	-10,278 Reduced 1.27%	800,054 $74.3 Billion
Q3 2017 Oct 12, 2017	BUY	$79.29 - $88.45 $64.3 Million - $71.7 Million	810,332	810,332 $69.5 Billion

Others Institutions Holding DHR

# of Institutions

2,388

Shares Held

563M

Call Options Held

3.94M

Put Options Held

4.1M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $194B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.

Account